Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication
Authors:
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 89 (6) , 1152-1159.e1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trialGastrointestinal Endoscopy, 2018
- Helicobacter pylori Therapy for the Prevention of Metachronous Gastric CancerNew England Journal of Medicine, 2018
- Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysisGastroenterology, 2016
- Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in JapanGastric Cancer, 2015
- Helicobacter pylori Update: Gastric Cancer, Reliable Therapy, and Possible BenefitsGastroenterology, 2015
- Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort studyGut, 2014
- Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trialsBMJ, 2014
- Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trialThe Lancet, 2008
- Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of ChinaJAMA, 2004
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001